Financials Omeros Corporation

Equities

OMER

US6821431029

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
3.15 USD +2.94% Intraday chart for Omeros Corporation +3.28% -3.67%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 762.8 880.7 402.1 141.8 205.6 182.5 - -
Enterprise Value (EV) 1 762.8 1,110 587.5 284.6 205.6 182.5 182.5 182.5
P/E ratio -8.24 x -5.93 x 2.06 x 2.97 x -1.74 x -1.51 x -1.75 x -2.19 x
Yield - - - - - - - -
Capitalization / Revenue 6.82 x 11.9 x 3.6 x - - - 28.1 x 8.11 x
EV / Revenue 6.82 x 11.9 x 3.6 x - - - 28.1 x 8.11 x
EV / EBITDA - -8,080,963 x -2,334,928 x -872,769 x - - - -
EV / FCF - - -3,655,915 x - - - - -
FCF Yield - - -0% - - - - -
Price to Book - -7.3 x 17 x 1.66 x - - - -
Nbr of stocks (in thousands) 54,137 61,652 62,542 62,730 62,865 57,943 - -
Reference price 2 14.09 14.28 6.430 2.260 3.270 3.150 3.150 3.150
Announcement Date 3/2/20 3/1/21 3/1/22 3/13/23 4/1/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 111.8 73.81 111.8 - - - 6.5 22.5
EBITDA - -109 -172.2 -162.4 - - - -
EBIT 1 -63.38 -110.6 -173.6 -163.4 -164.5 -159 -157.4 -142.4
Operating Margin -56.69% -149.84% -155.33% - - - -2,421.54% -632.89%
Earnings before Tax (EBT) 1 -84.49 -150.1 -191.5 -182 -174.9 -156.8 -159.6 -162.1
Net income 1 -84.49 -138.1 194.2 47.42 -117.8 -137.9 -134.8 -112
Net margin -75.57% -187.04% 173.78% - - - -2,073.85% -498%
EPS 2 -1.710 -2.410 3.120 0.7600 -1.880 -2.090 -1.795 -1.440
Free Cash Flow - - -110 - - - - -
FCF margin - - -98.42% - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 3/2/20 3/1/21 3/1/22 3/13/23 4/1/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 30 31.88 - - - - - - - - - - - -
EBITDA -17.94 -42.56 - - - - - - - - - - - -
EBIT 1 -18.25 -42.89 -35.05 -37.44 -50.77 -40.14 -35.71 -40.9 -48.15 -39.76 -36.15 -39.1 -42 -42.25
Operating Margin -60.84% -134.53% - - - - - - - - - - - -
Earnings before Tax (EBT) 1 -22.7 -47.31 -33.01 -41.7 -54.79 -46.05 -39.68 -44.29 -51.66 -39.29 -33.3 -39 -41.6 -42.9
Net income 1 -22.7 280.6 -33.01 -30.85 -17.46 128.7 -33.7 -37.29 -37.75 -9.068 -33.65 -34 -36.3 -33.95
Net margin -75.67% 880.24% - - - - - - - - - - - -
EPS 2 -0.3600 4.480 -0.5300 -0.4900 -0.2800 2.050 -0.5400 -0.5900 -0.6000 -0.1500 -0.5600 -0.5250 -0.5350 -0.4950
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 11/9/21 3/1/22 5/10/22 8/9/22 11/9/22 3/13/23 5/9/23 8/9/23 11/9/23 4/1/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - 230 185 143 - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - -2.106 x -1.076 x -0.8791 x - - - -
Free Cash Flow - - -110 - - - - -
ROE (net income / shareholders' equity) - 120% - - - - - -
ROA (Net income/ Total Assets) - - -63.8% - - - - -
Assets 1 - - -304.4 - - - - -
Book Value Per Share - -1.960 0.3800 1.360 - - - -
Cash Flow per Share - -1.750 -1.760 -1.380 - - - -
Capex 0.33 0.28 0.28 0.11 - - - -
Capex / Sales 0.3% 0.38% 0.25% - - - - -
Announcement Date 3/2/20 3/1/21 3/1/22 3/13/23 4/1/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
3.15
Average target price
-
Consensus
  1. Stock Market
  2. Equities
  3. OMER Stock
  4. Financials Omeros Corporation